The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies ...

Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a ...

Kailera Therapeutics launched on Tuesday as the latest startup seeking a slice of the booming market for anti-obesity therapies with a rare $400 million in early-stage funding.

Investors have been closely watching Roche's efforts to crack into the booming obesity market, which has lifted the fortunes of Novo Nordisk and Eli Lilly thanks to the huge popularity of drugs ...

The drug's efficacy, combined with an acceptable safety and tolerability profile, positions it as a potential game-changer in the obesity treatment landscape. 2. INV-202 (CB1 inverse agonist ...

Novo’s Wegovy carries a list price of $1,349 per month ... patients into the gray market for compounded versions of obesity drugs, which are cheaper and more plentiful, but lack any assurances ...

The committee stated that the current list price for Wegovy is $137 per month in Germany ... The timing was of interest to those who are waiting to see if there’s any chance of popular anti-obesity ...